-
Tech Industry Groups Blast Paris Accord Exit
President Trump’s decision, announced today, to withdraw from the international climate change agreement signed in 2015 received stiff rebukes from technology industry organizations.
-
Tech Matters: How Technology Could Help You To Trade Abroad
Trading overseas is always going to involve an element of risk. You just need to make sure you have all the best information and strategies to hand.
-
Precision Medicine Trial Shows Reduced Pain, Opioid Use
A large-scale clinical trial tracking pain treatments guided by genetic testing shows large majorities of participants report less pain, with fewer individuals using opioid drugs.
-
Does Your Start-up Have To Care About The Environment?
Environmental concerns are here to stay and this is something that your enterprise, big or small, will need to embrace.
-
Engineered Immune Cells to be Explored for Solid Tumors
A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers.
-
Methods to Enhance Workplace Productivity
You need to have a careful and considered approach to boosting productivity levels.
-
Fixed-Dose Blood Pressure Drugs Shown Cost-Effective
An analysis of medical insurance claims shows fixed-dose combination drugs to be the most cost-effective medication strategy for people with hypertension, or high blood pressure.
-
Geography Matters: Could You Be A Landlord From Afar?
If you want to make property investment your business, this can be hugely problematic.
-
Univ. Spin-Off Discovering New Antibiotics
A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria.
-
Bacteria Engineered to Act as Long-Term Gut Sensors
A bioengineering team developed a synthetic form of bacteria that live in the gut, and detect inflammation in lab mice for 6 months.